$1.56 Billion is the total value of Alphabet Inc.'s 51 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 17.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PATH | UIPATH INCcl a | $240,715,012 | +3.3% | 14,068,674 | 0.0% | 15.46% | +23.4% | |
| CRWD | CROWDSTRIKE HLDGS INCcl a | $214,862,861 | +14.0% | 1,283,683 | 0.0% | 13.80% | +36.2% | |
| VERV | VERVE THERAPEUTICS INC | $139,880,880 | -29.3% | 10,549,086 | 0.0% | 8.98% | -15.5% | |
| GITLAB INC | $119,711,448 | -11.5% | 2,647,312 | 0.0% | 7.69% | +5.8% | ||
| PRIME MEDICINE INC | $113,168,230 | -34.9% | 11,862,498 | 0.0% | 7.27% | -22.2% | ||
| EQRX INC | $105,839,557 | +19.4% | 47,675,476 | 0.0% | 6.80% | +42.7% | ||
| New | ARM HOLDINGS PLCsponsored adr | $104,941,160 | – | 1,960,784 | +100.0% | 6.74% | – | |
| PLANET LABS PBC | $83,050,867 | -19.3% | 31,942,641 | 0.0% | 5.33% | -3.5% | ||
| SNOW | SNOWFLAKE INCcl a | $81,824,223 | -13.2% | 535,604 | 0.0% | 5.26% | +3.8% | |
| OSCR | Sell | OSCAR HEALTH INCcl a | $80,638,973 | -58.4% | 14,477,374 | -39.8% | 5.18% | -50.3% |
| FRESHWORKS INC | $80,389,053 | +13.3% | 4,035,595 | 0.0% | 5.16% | +35.4% | ||
| DXCM | Sell | DEXCOM INC | $61,097,878 | -60.8% | 654,854 | -46.0% | 3.92% | -53.1% |
| DM | DESKTOP METAL INC | $16,131,145 | -17.5% | 11,048,730 | 0.0% | 1.04% | -1.4% | |
| RLAY | RELAY THERAPEUTICS INC | $13,193,212 | -33.0% | 1,568,753 | 0.0% | 0.85% | -20.0% | |
| SANA | SANA BIOTECHNOLOGY INC | $10,884,375 | -35.1% | 2,812,500 | 0.0% | 0.70% | -22.4% | |
| INVIVYD INC | $9,657,334 | +61.9% | 5,680,785 | 0.0% | 0.62% | +93.1% | ||
| RAPT | RAPT THERAPEUTICS INC | $8,979,287 | -11.1% | 540,270 | 0.0% | 0.58% | +6.3% | |
| LYEL | LYELL IMMUNOPHARMA INC | $8,621,733 | -53.8% | 5,865,125 | 0.0% | 0.55% | -44.7% | |
| BEAM | BEAM THERAPEUTICS INC | $7,734,576 | -24.7% | 321,604 | 0.0% | 0.50% | -10.0% | |
| ILMN | ILLUMINA INC | $7,340,361 | -26.8% | 53,470 | 0.0% | 0.47% | -12.6% | |
| GLUE | MONTE ROSA THERAPEUTICS INC | $7,012,631 | -30.1% | 1,464,015 | 0.0% | 0.45% | -16.5% | |
| BENSON HILL INC | $5,066,249 | -74.6% | 15,352,271 | 0.0% | 0.32% | -69.7% | ||
| VACC | VACCITECH PLCads | $4,677,159 | +50.0% | 1,513,644 | 0.0% | 0.30% | +78.6% | |
| VERA | VERA THERAPEUTICS INCcl a | $4,134,661 | -14.6% | 301,580 | 0.0% | 0.27% | +2.3% | |
| New | DIANTHUS THERAPEUTICS INC | $2,852,887 | – | 208,697 | +100.0% | 0.18% | – | |
| New | NEUMORA THERAPEUTICS INC. | $2,816,468 | – | 199,608 | +100.0% | 0.18% | – | |
| TSCAN THERAPEUTICS INC | $2,757,324 | +2.4% | 1,077,080 | 0.0% | 0.18% | +22.1% | ||
| FHTX | FOGHORN THERAPEUTICS INC | $2,504,505 | -29.0% | 500,901 | 0.0% | 0.16% | -14.8% | |
| TENAYA THERAPEUTICS INC | $2,335,047 | -56.6% | 915,705 | 0.0% | 0.15% | -48.1% | ||
| TSHA | TAYSHA GENE THERAPIES INC | $2,025,187 | +378.8% | 640,882 | 0.0% | 0.13% | +465.2% | |
| KRON | KRONOS BIO INC | $1,869,701 | -24.4% | 1,438,232 | 0.0% | 0.12% | -9.8% | |
| HYPERFINE INC | $1,842,376 | -4.7% | 898,720 | 0.0% | 0.12% | +13.5% | ||
| AUTL | AUTOLUS THERAPEUTICS PLCspon adr | $1,626,950 | -2.1% | 698,262 | 0.0% | 0.10% | +16.9% | |
| EXAS | EXACT SCIENCES CORP | $1,583,045 | -27.3% | 23,205 | 0.0% | 0.10% | -12.8% | |
| SCIENCE 37 HOLDINGS INC | $1,282,904 | +90.5% | 3,207,260 | 0.0% | 0.08% | +127.8% | ||
| ALEC | ALECTOR INC | $1,139,611 | +7.8% | 175,866 | 0.0% | 0.07% | +28.1% | |
| SPRO | SPERO THERAPEUTICS INC | $1,076,874 | -16.6% | 889,979 | 0.0% | 0.07% | 0.0% | |
| RANI THERAPEUTICS HLDGS INC | $973,227 | -47.3% | 448,492 | 0.0% | 0.06% | -36.4% | ||
| CRTX | QUINCE THERAPEUTICS INC | $211,817 | -25.8% | 189,122 | 0.0% | 0.01% | -6.7% | |
| EVELO BIOSCIENCES INC | $207,854 | +20.6% | 53,024 | 0.0% | 0.01% | +44.4% | ||
| NVTA | INVITAE CORP | $143,720 | -46.0% | 235,606 | 0.0% | 0.01% | -35.7% | |
| RGEN | REPLIGEN CORP | $60,901 | +12.4% | 383 | 0.0% | 0.00% | +33.3% | |
| FULC | FULCRUM THERAPEUTICS INC | $63,323 | +34.5% | 14,262 | 0.0% | 0.00% | +33.3% | |
| MONDEE HOLDINGS INC | $65,759 | -59.9% | 18,420 | 0.0% | 0.00% | -55.6% | ||
| CUE HEALTH INC | $11,880 | +18.9% | 27,000 | 0.0% | 0.00% | 0.0% | ||
| OPRT | Exit | Oportun Finl Corp | $0 | – | -94,788 | -100.0% | -0.03% | – |
| MGTA | Exit | Magenta Therapeutics Inc. | $0 | – | -3,339,138 | -100.0% | -0.14% | – |
| Exit | Robinhood Mkts Inc | $0 | – | -612,214 | -100.0% | -0.33% | – | |
| DBTX | Exit | Decibel Therapeutics Inc. | $0 | – | -1,636,258 | -100.0% | -0.34% | – |
| LYFT | Exit | Lyft Inc | $0 | – | -3,702,054 | -100.0% | -1.91% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPERO THERAPEUTICS INC | 24 | Q3 2023 | 3.5% |
| AUTOLUS THERAPEUTICS PLC | 22 | Q3 2023 | 2.8% |
| Magenta Therapeutics Inc. | 21 | Q2 2023 | 3.8% |
| DEXCOM INC | 20 | Q3 2023 | 17.4% |
| Evelo Biosciences Inc. | 20 | Q1 2023 | 1.6% |
| ALECTOR INC | 19 | Q3 2023 | 1.1% |
| Lyft Inc | 18 | Q2 2023 | 51.9% |
| QUINCE THERAPEUTICS INC | 18 | Q3 2023 | 0.6% |
| Arcus Biosciences Inc | 17 | Q1 2022 | 12.7% |
| FULCRUM THERAPEUTICS INC | 17 | Q3 2023 | 0.7% |
View Alphabet Inc.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ARRIS International plc | February 14, 2019 | 7,603,500 | 4.4% |
View Alphabet Inc.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-04-17 |
| 144 | 2024-04-17 |
| 4 | 2024-04-17 |
| 4 | 2024-04-15 |
| 144 | 2024-04-12 |
| 4 | 2024-04-04 |
| 144 | 2024-04-03 |
| 144 | 2024-04-03 |
| 4 | 2024-04-02 |
| 4 | 2024-04-02 |
View Alphabet Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.